India must manufacture more APIs locally, depend less on China: Experts

India, the world's third-largest drug producer by volumes, imports 70%
of its APIs from China. For some APIs, especially antibiotics,
dependence on China is over 90%. India's top drug makers, including Dr
Reddy's, Lupin, Glenmark, Mylan, Zydus and Pfizer are dependent on
China for APIs.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-must-manufacture-more-apis-locally-depend-less-on-china-experts/articleshow/76436167.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment